US FDA Needs Plan For Addressing Inspection Backlog Post-COVID, GAO Says

 
• By Joanne S. Eglovitch
Facility inspection
GAO Tells FDA Not To Compromise High-Risk Facility Inspections Due To COVID-19 Backlog • Source: Shutterstock

More from Manufacturing

More from Compliance